Valuation: Pacific Biosciences of California, Inc.

Market Cap 551M 502M 465M 420M 788M 51.44B 825M 5.61B 2.23B 27.8B 2.07B 2.02B 88.05B P/E 2026 *
-4.22x
P/E 2027 * -3.89x
Enterprise Value 1.02B 926M 857M 775M 1.45B 94.91B 1.52B 10.36B 4.11B 51.29B 3.81B 3.73B 162B EV / Sales 2026 *
6.45x
EV / Sales 2027 * 6x
Free-Float
91.2%
Yield 2026 *
-
Yield 2027 * -
1 day-3.83%
1 week-10.66%
Current month-32.44%
1 month-4.35%
3 months+38.58%
6 months+53.04%
Current year-5.88%
1 week 1.71
Extreme 1.71
2.02
1 month 1.71
Extreme 1.71
3.06
Current year 1.07
Extreme 1.07
3.44
1 year 1.07
Extreme 1.07
3.44
3 years 0.85
Extreme 0.8511
10.65
5 years 0.85
Extreme 0.8511
26.34
10 years 0.85
Extreme 0.8511
53.69
Manager TitleAgeSince
Chief Executive Officer 53 05/08/2026
Chief Tech/Sci/R&D Officer - 01/07/2012
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 67 01/01/2004
Director/Board Member 72 01/01/2009
Director/Board Member 69 18/01/2012
Date Insider Type Main position Quantity % Market Cap. Importance
6/10/26 Exercice

Chief Financial Officer

1,661,815 0.5346%
17/8/26 Sell

Chief Executive Officer

-26,911 0.0087%
10/8/26 Free

Chief Executive Officer

2,457,018 0.7911%
Change 5-day change 1-year change 3-year change Capi.($)
-3.83%-10.66%0.00%-79.05% 551M
-0.58%-1.53%+20.04%+47.67% 255B
-0.45%-1.98%+2.32%+9.52% 160B
-3.26%-7.42%-27.88%+33.40% 141B
-1.49%-2.74%-55.68%-20.89% 62.31B
-1.28%-1.81%+20.76%+55.28% 59.73B
-0.49%-0.71%+5.69%-12.72% 53.49B
-1.12%+1.35%+21.43%+54.96% 49.43B
-2.06%-1.24%+21.32%+74.31% 44.87B
-5.15%-13.06%-3.69%+48.93% 42.57B
Average -1.44%-4.04%+0.43%+21.14% 87B
Weighted average by Cap. -0.57%-3.61%+1.70%+31.99%

Financials

2026 *2027 *
Net sales 157M 143M 133M 120M 225M 14.71B 236M 1.61B 637M 7.95B 591M 578M 25.18B 178M 162M 150M 136M 255M 16.63B 267M 1.82B 720M 8.99B 668M 654M 28.47B
Net income -130M -119M -110M -99.36M -186M -12.16B -195M -1.33B -527M -6.57B -489M -478M -20.82B -144M -131M -121M -110M -206M -13.44B -216M -1.47B -582M -7.26B -540M -529M -23.01B
Net Debt 466M 424M 393M 355M 666M 43.48B 697M 4.75B 1.88B 23.49B 1.75B 1.71B 74.42B 518M 472M 437M 395M 742M 48.41B 776M 5.28B 2.1B 26.16B 1.94B 1.9B 82.86B
Projected Income Statement - Annual - Pacific Biosciences of California, Inc.
Logo Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops, and manufactures sequencing solutions. Its products and technology include HiFi long-read sequencing technology, which addresses a set of applications including human germline sequencing, plant and animal sciences, infectious disease, microbiology, oncology, and other applications. Its sequencing technology supports oncology research by enabling analysis of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), providing researchers with insight into cancer biology. It focuses on creating sequencing systems to provide customers with a view of genomes, transcriptomes, and epigenomes. Its customers include academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations (CROs), pharmaceutical companies, and agricultural companies.
Employees
485
Date Price Change Volume
19/11/26 USD 1.760 -3.83% 20,002,001
18/11/26 USD 1.830 +0.55% 15,315,685
17/11/26 USD 1.820 -1.09% 13,344,810
16/11/26 USD 1.840 -6.12% 14,412,378
13/11/26 USD 1.960 -0.51% 7,020,622
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - Pacific Biosciences of California, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
1.760USD
Average target price
2.743USD
Spread / Average Target
+55.84%
  1. Stock Market
  2. Stocks
  3. PACB Stock